Bolan, Patrick O <br/><br/>
Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization.  [electronic resource] 

 -  Cell systems  01 2020 
 - 52-65.e7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2405-4720 
<br/><br/><label>Standard No.: </label>10.1016/j.cels.2019.10.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--administration & dosage<br/>Adenocarcinoma of Lung--drug therapy<br/>Aniline Compounds--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Benzimidazoles--administration & dosage<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--genetics<br/>Erlotinib Hydrochloride--administration & dosage<br/>Genetic Fitness<br/>Genotype<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>MAP Kinase Signaling System<br/>Mutation